BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 21116837)

  • 1. Inhibition of Nodal suppresses angiogenesis and growth of human gliomas.
    Hueng DY; Lin GJ; Huang SH; Liu LW; Ju DT; Chen YW; Sytwu HK; Chang C; Huang SM; Yeh YS; Lee HM; Ma HI
    J Neurooncol; 2011 Aug; 104(1):21-31. PubMed ID: 21116837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of hypoxia inducible factor-1alpha (HIF-1alpha) decreases vascular endothelial growth factor (VEGF) secretion and tumor growth in malignant gliomas.
    Jensen RL; Ragel BT; Whang K; Gillespie D
    J Neurooncol; 2006 Jul; 78(3):233-47. PubMed ID: 16612574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flavopiridol downregulates hypoxia-mediated hypoxia-inducible factor-1alpha expression in human glioma cells by a proteasome-independent pathway: implications for in vivo therapy.
    Newcomb EW; Ali MA; Schnee T; Lan L; Lukyanov Y; Fowkes M; Miller DC; Zagzag D
    Neuro Oncol; 2005 Jul; 7(3):225-35. PubMed ID: 16053697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nodal regulates energy metabolism in glioma cells by inducing expression of hypoxia-inducible factor 1α.
    Lai JH; Jan HJ; Liu LW; Lee CC; Wang SG; Hueng DY; Cheng YY; Lee HM; Ma HI
    Neuro Oncol; 2013 Oct; 15(10):1330-41. PubMed ID: 23911596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolinderalactone suppresses human glioblastoma growth and angiogenic activity in 3D microfluidic chip and in vivo mouse models.
    Park JH; Kim MJ; Kim WJ; Kwon KD; Ha KT; Choi BT; Lee SY; Shin HK
    Cancer Lett; 2020 May; 478():71-81. PubMed ID: 32173479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of Delta-like ligand 4 (DLL4) with VEGF and HIF-1α expression in human glioma.
    Li Z; Wang J; Gong L; Wen Z; Xu C; Huang X
    Asian Pac J Cancer Prev; 2011; 12(1):215-8. PubMed ID: 21517260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNA interference targeting hypoxia-inducible factor 1α via a novel multifunctional surfactant attenuates glioma growth in an intracranial mouse model.
    Gillespie DL; Aguirre MT; Ravichandran S; Leishman LL; Berrondo C; Gamboa JT; Wang L; King R; Wang X; Tan M; Malamas A; Lu ZR; Jensen RL
    J Neurosurg; 2015 Feb; 122(2):331-41. PubMed ID: 25423275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant activation of Hedgehog/Gli1 pathway on angiogenesis in gliomas.
    Cui D; Chen X; Yin J; Wang W; Lou M; Gu S
    Neurol India; 2012; 60(6):589-96. PubMed ID: 23287320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PAX6 suppression of glioma angiogenesis and the expression of vascular endothelial growth factor A.
    Zhou YH; Hu Y; Mayes D; Siegel E; Kim JG; Mathews MS; Hsu N; Eskander D; Yu O; Tromberg BJ; Linskey ME
    J Neurooncol; 2010 Jan; 96(2):191-200. PubMed ID: 19618119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AQP-4 in peritumoral edematous tissue is correlated with the degree of glioma and with expression of VEGF and HIF-alpha.
    Mou K; Chen M; Mao Q; Wang P; Ni R; Xia X; Liu Y
    J Neurooncol; 2010 Dec; 100(3):375-83. PubMed ID: 20467785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-angiogenic effects of SN38 (active metabolite of irinotecan): inhibition of hypoxia-inducible factor 1 alpha (HIF-1alpha)/vascular endothelial growth factor (VEGF) expression of glioma and growth of endothelial cells.
    Kamiyama H; Takano S; Tsuboi K; Matsumura A
    J Cancer Res Clin Oncol; 2005 Apr; 131(4):205-13. PubMed ID: 15583935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of anti-tumor activity by low-dose combination of the recombinant urokinase kringle domain and celecoxib in a glioma model.
    Kim CK; Joe YA; Lee SK; Kim EK; O E; Kim HK; Oh BJ; Hong SH; Hong YK
    Cancer Lett; 2010 Feb; 288(2):251-60. PubMed ID: 19664879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KDM1 is a novel therapeutic target for the treatment of gliomas.
    Sareddy GR; Nair BC; Krishnan SK; Gonugunta VK; Zhang QG; Suzuki T; Miyata N; Brenner AJ; Brann DW; Vadlamudi RK
    Oncotarget; 2013 Jan; 4(1):18-28. PubMed ID: 23248157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of connective tissue growth factor on hypoxia-inducible factor 1alpha degradation and tumor angiogenesis.
    Chang CC; Lin MT; Lin BR; Jeng YM; Chen ST; Chu CY; Chen RJ; Chang KJ; Yang PC; Kuo ML
    J Natl Cancer Inst; 2006 Jul; 98(14):984-95. PubMed ID: 16849681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxia inducible factor-1α/vascular endothelial growth factor signaling activation correlates with response to radiotherapy and its inhibition reduces hypoxia-induced angiogenesis in lung cancer.
    Zhu H; Zhang S
    J Cell Biochem; 2018 Sep; 119(9):7707-7718. PubMed ID: 29904944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The chemokine CXCL12 and its receptor CXCR4 promote glioma stem cell-mediated VEGF production and tumour angiogenesis via PI3K/AKT signalling.
    Ping YF; Yao XH; Jiang JY; Zhao LT; Yu SC; Jiang T; Lin MC; Chen JH; Wang B; Zhang R; Cui YH; Qian C; Wang Jm; Bian XW
    J Pathol; 2011 Jul; 224(3):344-54. PubMed ID: 21618540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heat Shock Protein 47 Promotes Glioma Angiogenesis.
    Wu ZB; Cai L; Lin SJ; Leng ZG; Guo YH; Yang WL; Chu YW; Yang SH; Zhao WG
    Brain Pathol; 2016 Jan; 26(1):31-42. PubMed ID: 25758142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of hypoxia inducible factor-1alpha by dihydroxyphenylethanol, a product from olive oil, blocks microsomal prostaglandin-E synthase-1/vascular endothelial growth factor expression and reduces tumor angiogenesis.
    Terzuoli E; Donnini S; Giachetti A; Iñiguez MA; Fresno M; Melillo G; Ziche M
    Clin Cancer Res; 2010 Aug; 16(16):4207-16. PubMed ID: 20682710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon-β inhibits glioma angiogenesis through downregulation of vascular endothelial growth factor and upregulation of interferon inducible protein 10.
    Takano S; Ishikawa E; Matsuda M; Yamamoto T; Matsumura A
    Int J Oncol; 2014 Nov; 45(5):1837-46. PubMed ID: 25175315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of tumor angiogenesis by metformin treatment via a mechanism linked to targeting of HER2/HIF-1α/VEGF secretion axis.
    Wang J; Li G; Wang Y; Tang S; Sun X; Feng X; Li Y; Bao G; Li P; Mao X; Wang M; Liu P
    Oncotarget; 2015 Dec; 6(42):44579-92. PubMed ID: 26625311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.